Treatment for Avascular Necrosis of the Left Hip in a 38-Year-Old Female with Diabetes and Rheumatoid Arthritis
For this young patient with steroid-induced hip AVN (likely from RA treatment), initiate an individualized exercise program with joint protection strategies, appropriate walking aids, and pain management while optimizing her rheumatoid arthritis control—and prepare for surgical consultation if imaging shows stage III or IV disease with joint surface collapse. 1
Initial Assessment and Staging
Obtain MRI imaging immediately to stage the AVN, as this is the most sensitive diagnostic modality and will determine your treatment pathway 2, 3. Plain radiographs may be normal in early disease 3.
Stage I-II (preserved joint surface):
- Joint surface remains intact
- Conservative management is recommended
- Focus on joint preservation 2
Stage III-IV (joint surface collapse):
Conservative Management for Early-Stage Disease
Exercise and Rehabilitation Program
Implement a daily exercise regimen that includes 1:
- Strengthening exercises for quadriceps and hip girdle muscles bilaterally
- Aerobic activity appropriate to the patient's current capabilities
- Range of motion and stretching exercises to maintain joint mobility
- Use a "small amounts often" pacing approach, starting at manageable levels and gradually increasing intensity over months 1
Joint Protection Strategies
- Prescribe a cane for the contralateral side to reduce loading on the affected hip 1
- Recommend appropriate footwear to minimize joint stress 1
- Consider assistive technology: raised chairs, beds, toilet seats, hand-rails for stairs, walk-in shower instead of bath 1
Pain Management
Use appropriate analgesics while avoiding excessive loading of the affected hip, which may accelerate disease progression 1. The goal is to maintain function while protecting the joint.
Weight Management
If the patient is overweight, implement weight loss strategies including regular physical activity as tolerated, structured meal planning, and regular monitoring 1. This is particularly important given her diabetes.
Optimize Rheumatoid Arthritis Control
Critical consideration: Glucocorticoid use is one of the most important causes of AVN 3. Review her current RA treatment regimen.
- Minimize or withdraw glucocorticoids if her underlying RA allows 3
- Ensure she is on optimal disease-modifying antirheumatic drug (DMARD) therapy, typically methotrexate as first-line 4, 5
- Target remission or low disease activity (SDAI ≤3.3 or CDAI ≤2.8 for remission) 4
- Monitor disease activity every 1-3 months and adjust therapy if target is not reached within 3-6 months 4
The relationship between AVN and glucocorticoid dosage is complex, with some studies demonstrating cumulative dose as the most important determining factor 3.
Patient Education and Self-Management
Provide individualized education about 1:
- Disease progression and prognosis
- Self-management strategies
- Realistic short-term and long-term goals with regular follow-up
- Include partners/carers when appropriate 1
Surgical Considerations
For stage III-IV disease with joint surface collapse:
- In young patients like this 38-year-old, joint-preserving procedures should be prioritized when appropriate 1
- Options include core decompression, osteotomy, bone grafting, tantalum rod insertion, or ultimately joint replacement 2, 3
- Recent advances include mesenchymal stem cell therapy, though this remains investigational 2
- Hip arthroplasty is the definitive treatment for advanced disease with severe symptoms poorly controlled by medical management 2, 5
Vocational Rehabilitation
Given her young age, provide counseling about 1:
- Modifying work-related factors
- Altering work tasks or hours
- Workplace modifications to prevent work disability
Critical Pitfalls to Avoid
- Do not delay MRI imaging if plain radiographs are normal but clinical suspicion is high—MRI is far more sensitive for early-stage AVN 2, 3
- Avoid excessive loading of the affected hip, which accelerates disease progression 1
- Do not continue high-dose glucocorticoids without attempting to minimize or withdraw them if clinically feasible 3
- Do not treat AVN in isolation—optimize her RA control simultaneously to prevent further joint damage 4
The efficacy of bisphosphonates in reducing femoral head collapse remains controversial and is not routinely recommended 3.